Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer

Archives of Gynecology and Obstetrics

Volumn 288, Issue 6, 2013, Pages 1391-1397

  Vaizoglu, Ferdi ^a   Yuce, Kunter ^a   Salman, Mehmet Coskun ^a   Basaran, Derman ^a   Calis, Pinar ^a   Ozgul, Nejat ^a   Usubutun, Alp ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Endometrial cancer; Lymph node metastasis; Lymphadenectomy; Lymphovascular space involvement

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER PROGNOSIS; CANCER STAGING; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHOVASCULAR SPACE INVOLVEMENT; MAJOR CLINICAL STUDY; ONCOLOGICAL PARAMETERS; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TUMOR INVASION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PELVIS; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES;

EID: 84889100427     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2913-x     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893-2917
2. Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105(2):103-104
3. Kehoe SM, Miller DS (2011) The role of lymphadenectomy in endometrial cancer. Clin Obstet Gynecol 54(2):235-244
4. Lee KB, Ki KD, Lee JM, Lee JK, Kim JW, Cho CH et al (2009) The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study. Ann Surg Oncol 16(10):2882-2887
5. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR et al (2012) Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 127(1):5-10
6. Turan T, Hizli D, Sarici S, Boran N, Gundogdu B, Karadag B et al (2011) Is it possible to predict para-aortic lymph node metastasis in endometrial cancer? Eur J Obstet Gynecol Reprod Biol 158(2):274-279
7. Taskiran C, Yuce K, Geyik PO, Kucukali T, Ayhan A (2006) Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer. Int J Gynecol Cancer 16(3):1342-1347
8. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125-136
9. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100(23):1707-1716
10. Loubeyre P, Undurraga M, Bodmer A, Petignat P (2011) Non-invasive modalities for predicting lymph node spread in early stage endometrial cancer? Surg Oncol 20(2):e102-e108
11. Connor JP, Andrews JI, Anderson B, Buller RE (2000) Computed tomography in endometrial carcinoma. Obstet Gynecol 95(5):692-696
12. Park JY, Kim EN, Kim DY, Suh DS, Kim JH, Kim YM et al (2008) Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol 108(3):486-492
13. van Doorn HC, van der Zee AG, Peeters PH, Kroeks MV, van Eijkeren MA (2002) Preoperative selection of patients with low-stage endometrial cancer at high risk of pelvic lymph node metastases. Int J Gynecol Cancer 12(2):144-148
14. Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC et al (2012) A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol 127(3):525-531
15. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60(8 Suppl):2035-2041
16. Chi DS, Barakat RR, Palayekar MJ, Levine DA, Sonoda Y, Alektiar K et al (2008) The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 18(2):269-273
17. Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL (2012) Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol 119(2 Pt 1):286-292
18. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC (2000) Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182(6):1506-1519
19. Gadducci A, Cavazzana A, Cosio S, DIC C, Tana R, Fanucchi A et al (2009) Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer. Anticancer Res 29(5):1715-1720
20. Guntupalli SR, Zighelboim I, Kizer NT, Zhang Q, Powell MA, Thaker PH et al (2012) Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. Gynecol Oncol 124(1):31-35
21. Briet JM, Hollema H, Reesink N, Aalders JG, Mourits MJ, ten Hoor KA et al (2005) Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 96(3):799-804
22. Zhang C, Wang C, Feng W (2012) Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma. Int J Gynecol Cancer 22(8):1373-1377
23. Chang SJ, Kong TW, Kim WY, Yoo SC, Yoon JH, Chang KH et al (2011) Lymph-vascular space invasion as a significant risk factor for isolated para-aortic lymph node metastasis in endometrial cancer: a study of 203 consecutive patients. Ann Surg Oncol 18(1):58-64
24. Kumar S, Bandyopadhyay S, Semaan A, Shah JP, Mahdi H, Morris R et al (2011) The role of frozen section in surgical staging of low risk endometrial cancer. PLoS One 6(9):e21912
25. Cohn DE, Horowitz NS, Mutch DG, Kim SM, Manolitsas T, Fowler JM (2002) Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 87(3):243-246
26. McMeekin DS, Lashbrook D, Gold M, Scribner DR, Kamelle S, Tillmanns TD et al (2001) Nodal distribution and its significance in FIGO stage IIIc endometrial cancer. Gynecol Oncol 82(2):375-379
27. Fujimoto T, Nanjyo H, Nakamura A, Yokoyama Y, Takano T, Shoji T et al (2007) Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Gynecol Oncol 107(2):253-259
28. Fujimoto T, Nanjyo H, Fukuda J, Nakamura A, Mizunuma H, Yaegashi N et al (2009) Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence. Gynecol Oncol 112(2):342-347
29. Todo Y, Kato H, Minobe S, Okamoto K, Suzuki Y, Sudo S et al (2011) Initial failure site according to primary treatment with or without para-aortic lymphadenectomy in endometrial cancer. Gynecol Oncol 121(2):314-318